1. Scrip
  2. >>Therapy Areas

ALS drug development lukewarm despite icy hot challenge

 
• By Lisa LaMotta

The ALS Ice Bucket Challenge has brought awareness, money and even controversy to a rare disease that is both debilitating and fatal to the 5,600 people diagnosed per year, yet it hasn't poured new drug opportunities into the development pipeline.

The ALS Ice Bucket Challenge has brought awareness, money and even controversy to a rare disease that is both debilitating and fatal to the 5,600 people diagnosed per year, yet it hasn't poured new drug opportunities into the development pipeline.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Neurological

More from Therapy Areas

Scancell Signs UK Match-Making Pact For Melanoma Vaccine

 
• By Kevin Grogan

The Oxford group has linked up with the NHS Cancer Vaccine Launch Pad.

Bristol’s Opdivo + Yervoy Gets FDA Liver, Colorectal Cancer Nods

 
• By Joseph Haas

Bristol Myers Squibb notched two approvals in one week for its immuno-oncology combination, pitting the regimen head-to-head with Keytruda in a subset of CRC and with two combos in HCC.

J&J’s Icotrokinra Scores In Important Adolescent Patient Segment

 
• By Alaric DeArment

The company presented positive Phase III data from a subset analysis of ICONIC-LEAD comprising patients with moderate-to-severe plaque psoriasis.